Sreedhar Chava, MD
Family Medicine · El Monte, CANPI 1255515383
Payments from drug & device makers
Across 136 payments — averaging $9469.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$777K
- Roche Diagnostics Operations, Inc.$497K
- GSK$12K
- Merck$634
- Sanofi Pasteur Inc.$229
- Amgen$137
- plus $1K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 16 | $777,367 |
| Roche Diagnostics Operations, Inc. | 5 | $496,783 |
| GSK | 10 | $11,525 |
| Merck | 28 | $634 |
| Sanofi Pasteur Inc. | 12 | $229 |
| Amgen | 7 | $137 |
| Novo Nordisk | 5 | $115 |
| Pfizer | 5 | $105 |
| Cranial Technologies, Inc | 5 | $102 |
| Shield Therapeutics Inc | 5 | $95 |
| Xeris Pharmaceuticals, Inc. | 4 | $85 |
| AstraZeneca | 5 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $69 |
| Lilly USA, LLC | 2 | $57 |
| Agile Therapeutics, Inc. | 3 | $57 |
| AbbVie(2 entities) | 3 | $55 |
| Ultragenyx Pharmaceutical Inc. | 2 | $44 |
| Johnson & Johnson | 2 | $41 |
| Boehringer Ingelheim | 2 | $36 |
| Exact Sciences | 2 | $33 |
| Novartis | 1 | $25 |
| Dermira, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $20 |
| Boston Scientific | 1 | $20 |
| Organon | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Avion Pharmaceuticals | 1 | $12 |
How this compares
$1,287,822 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in El Monte
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.